 The overall primary objective of the study is to determine whether patients with poor glycemic control as evidenced by HbA1c 8.1 can achieve improved metabolic control using the real-time values of the Guardian RT compared to conventional self-monitoring blood glucose finger-sticks control group after 12 weeks of continuous use. 